In cell-based experiments, TIMP-3 was reported to suppress cell migration and invasion by inhibiting the activity of MMPs and ADAMs in many cancers such as NSCLC, thyroid cancer, melanomas, liver cancer, and colorectal cancer [12,32,33,34]. Here, TIMP3 is linked to non-small cell lung carcinoma.